Difficulty: Medium
Average Score: 80%
Practice
Suramin is an antagonist of ________ receptors
Correct answer
A
Rationale
Rationale:
Suramin is a medication that is primarily known for its use in treating African sleeping sickness, river blindness, and certain types of cancer. In the context of CNS Pharmacology, Suramin is an antagonist of purine receptors, specifically P2 receptors.
A) Purine: This is the correct answer. Suramin acts as an antagonist at purine receptors, particularly P2 receptors. By blocking these receptors, Suramin exerts its pharmacological effects.
B) Somatostatin: Somatostatin receptors are not the target of Suramin. Somatostatin receptors are involved in the regulation of various physiological processes, but Suramin does not interact with them.
C) Neuropeptide Y: Suramin does not antagonize Neuropeptide Y receptors. Neuropeptide Y is involved in the regulation of appetite, energy balance, and stress responses, but Suramin does not affect its receptors.
D) Neurotensin: Suramin does not act on Neurotensin receptors. Neurotensin is a neurotransmitter that plays a role in pain modulation, regulation of dopamine signaling, and other functions, but Suramin does not target its receptors.
Educational Context:
Understanding the pharmacological actions of drugs is crucial for healthcare professionals to make informed decisions regarding patient care. In the case of CNS pharmacology, knowing the specific receptor targets of drugs like Suramin helps in predicting their effects and potential side effects. This knowledge allows for the rational selection of medications and the management of drug interactions. It also underscores the importance of understanding drug-receptor interactions in designing effective treatment regimens for various CNS disorders.
Suramin is a medication that is primarily known for its use in treating African sleeping sickness, river blindness, and certain types of cancer. In the context of CNS Pharmacology, Suramin is an antagonist of purine receptors, specifically P2 receptors.
A) Purine: This is the correct answer. Suramin acts as an antagonist at purine receptors, particularly P2 receptors. By blocking these receptors, Suramin exerts its pharmacological effects.
B) Somatostatin: Somatostatin receptors are not the target of Suramin. Somatostatin receptors are involved in the regulation of various physiological processes, but Suramin does not interact with them.
C) Neuropeptide Y: Suramin does not antagonize Neuropeptide Y receptors. Neuropeptide Y is involved in the regulation of appetite, energy balance, and stress responses, but Suramin does not affect its receptors.
D) Neurotensin: Suramin does not act on Neurotensin receptors. Neurotensin is a neurotransmitter that plays a role in pain modulation, regulation of dopamine signaling, and other functions, but Suramin does not target its receptors.
Educational Context:
Understanding the pharmacological actions of drugs is crucial for healthcare professionals to make informed decisions regarding patient care. In the case of CNS pharmacology, knowing the specific receptor targets of drugs like Suramin helps in predicting their effects and potential side effects. This knowledge allows for the rational selection of medications and the management of drug interactions. It also underscores the importance of understanding drug-receptor interactions in designing effective treatment regimens for various CNS disorders.